Ticker LaunchReverse merger · Completed · SEEL
Seelos Therapeutics, Inc.
Reverse merger with Apricus Biosciences, Inc. (APRI)
Seelos Therapeutics, Inc. merged into Apricus Biosciences, Inc. (APRI), a Nasdaq-listed biopharmaceutical company, in a reverse merger that takes the private company public. The deal was announced on Jul 30, 2018 and closed on Jan 24, 2019. The combined company trades as Seelos Therapeutics, Inc. (SEEL) on Nasdaq.
Seelos Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for central nervous system disorders, with late-stage candidates including SLS-002, an intranasal racemic ketamine for suicidality in PTSD and major depressive disorder.
- Status
- Completed
- Private company
- Seelos Therapeutics, Inc.
- Public company
- Apricus Biosciences, Inc. (APRI)
- Public company business before
- Nasdaq-listed biopharmaceutical company
- Announced
- Jul 30, 2018
- Closed
- Jan 24, 2019
- Combined company
- Seelos Therapeutics, Inc. (SEEL)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- 8-K (merger completion) Jan 24, 2019
- Exhibit 99.1 (completion press release/exhibit)
- All filings on EDGAR CIK 1017491
Other completed reverse mergers
- X4 Therapeutics, Inc.into Arsanis, Inc. · Mar 13, 2019
- OWP Ventures, Inc.into Punto Group, Corp. (One World Pharma, Inc.) · Feb 21, 2019
- Lovego Holdings Limitedinto Quintec Corp (Love International Group) · Feb 11, 2019
- SCWorx Corp.into Alliance MMA, Inc. · Feb 1, 2019
- Yunguhui Group Limitedinto Capstone Systems Inc. · Jan 14, 2019
- IBASE Technology Private Limitedinto TechMedia Advertising, Inc. · Jan 3, 2019